RecruitingNot ApplicableNCT07092761
Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System
Sponsor
Henan University of Science and Technology
Enrollment
82 participants
Start Date
Apr 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The study is to evaluate the accuracy and safety of a novel real-time CGM system among adult patients with type 1 diabetes mellitus with respect to YSI reference venous plasma sample measurements.
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called GS3 CGM for people with type1diabetes. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEGS3 CGM
Wearing CGM for a consecutive 14 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07092761
Related Trials
Safety and Effectiveness of A Novel Continuous Glucose and Ketone Monitoring System
NCT071398082 locations
Thrive With Type 1 Diabetes 2026
NCT075228662 locations
Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System
NCT07745244
SGLT2i, Pioglitazone, and Ketone Production in T1D
NCT070566991 location
Exercise Training and Endothelial Function in Type 1 Diabetes
NCT035282261 location